CIRCADIAN VARIATION OF ENDOTHELIAL-CELL FUNCTION, RED-BLOOD-CELL DEFORMABILITY AND DEHYDRO-THROMBOXANE-B2 IN HEALTHY-VOLUNTEERS

被引:34
作者
BRIDGES, AB [1 ]
MCLAREN, M [1 ]
SANIABADI, A [1 ]
FISHER, TC [1 ]
BELCH, JJF [1 ]
机构
[1] UNIV DUNDEE,NINEWELLS HOSP & MED SCH,SCH MED,DUNDEE DD1 9SY,SCOTLAND
关键词
ENDOTHELIAL CELLS; CIRCADIAN VARIATION; VONWILLEBRAND FACTOR; TISSUE PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR; RED CELL DEFORMABILITY;
D O I
10.1097/00001721-199106000-00007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There is a circadian variation in the time of onset of thrombotic disorders. The thrombotic tendency of blood is influenced by many factors including complex interactions between endothelial cells, platelets and red blood cells. We studied the circadian variation of various indices of these cells' functions in 10 young healthy male volunteers. Six blood samples were collected at 4 h intervals from 12.00 until 08.00 the following morning. The volunteers carried out normal daily activities until 00.00 at which time they went to bed. They remained in bed until 08.00 the following morning. The following were measured on each sample: plasma factor VIII von Willebrand factor antigen (FVIII vWF Ag), tissue plasminogen activator activity (tPA), plasminogen activator inhibitor (PAI), prostacyclin stimulating factor (PGI2 SF), fibrinopeptide A (FPA), 11 dehydro-thromboxane B2 (11-dehydro-TXB2) and red cell deformability (RCD). The following parameters demonstrated significant circadian variation: tPA P < 0.001, PAI P < 0.04 and 11-dehydro-TXB2 P < 0.005 (two-way analysis of variance). tPA was highest at 16.00-20.00 and lowest at 08.00; PAI was highest at 08.00 and lowest at 20.00; TXB2 had a peak at 16.00 and trough at 04.00. As the behaviour of endothelial cells and platelets influence the rheological properties of blood, circadian variations in their behaviour may contribute to the time of onset of thrombotic disorders.
引用
收藏
页码:447 / 452
页数:6
相关论文
共 39 条
[21]   THE EFFECT OF ADRENERGIC-STIMULATION ON URINARY PROSTAGLANDIN-E2 AND 6 KETO PGF-1-ALPHA IN MAN [J].
NADLER, J ;
ZIPSER, RD ;
HORTON, R .
PROSTAGLANDINS, 1983, 26 (04) :519-530
[22]   DIURNAL-VARIATION AND EXERCISE INDUCED CHANGES OF PROSTACYCLIN IN MAN [J].
NADLER, JL ;
YAMAMOTO, JV .
PROSTAGLANDINS LEUKOTRIENES AND MEDICINE, 1986, 22 (01) :71-78
[23]  
PETRALITO A, 1982, CHRONOBIOLOGIA, V9, P195
[24]  
PRENTICE CRM, 1972, THROMB RES, V1, P493
[25]  
PUGLIESE F, 1983, PROSTAGLANDINS KIDNE
[27]   FAMILIAL DEFICIENCY OF A PLASMA FACTOR STIMULATING VASCULAR PROSTACYCLIN ACTIVITY [J].
REMUZZI, G ;
MARCHESI, D ;
MISIANI, R ;
MECCA, G ;
GAETANO, GD ;
DONATI, MB .
THROMBOSIS RESEARCH, 1979, 16 (3-4) :517-525
[28]   CIRCADIAN VARIATION OF TRANSIENT MYOCARDIAL-ISCHEMIA IN PATIENTS WITH CORONARY-ARTERY DISEASE [J].
ROCCO, MB ;
BARRY, J ;
CAMPBELL, S ;
NABEL, E ;
COOK, EF ;
GOLDMAN, L ;
SELWYN, AP .
CIRCULATION, 1987, 75 (02) :395-400
[29]   BLOOD FIBRINOLYTIC ACTIVITY IN MAN - DIURNAL VARIATION AND RESPONSE TO VARYING INTENSITIES OF EXERCISE [J].
ROSING, DR ;
BRAKMAN, P ;
REDWOOD, DR ;
GOLDSTEIN, RE ;
BEISER, GD ;
ASTRUP, T ;
EPSTEIN, SE .
CIRCULATION RESEARCH, 1970, 27 (02) :171-+
[30]   DISSOCIATION AND DIURNAL-VARIATION OF PROSTAGLANDIN-E2 6-KETO-PROSTAGLANDIN-F1-ALPHA, AND THROMBOXANE-B2 EXCRETION IN HEALTHY FEMALES [J].
RUBIN, PD ;
HANSEN, RG ;
PIETROWIAK, C .
PROSTAGLANDINS LEUKOTRIENES AND MEDICINE, 1987, 27 (2-3) :105-117